Journals / art / 2019 / Cilt: 34 - Sayı: 3

Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis

Journal
art
Pages
317–325
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While CPET parameters are affected by spinal mobility, declining aerobic capacity affects QoL.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to evaluate the cardiopulmonary functions and exercise performance of patients with ankylosing spondylitis (AS) andto investigate the relationship between these parameters and disease activity, spine mobility and quality of life (QoL).Patients and methods: Forty-five patients with AS (group 1; 33 males, 12 females; mean age 43.1±12.1 years; range 22 to 70 years) and 30 controlsubjects (group 2; 23 males, 7 females; mean age 42.8±10.0; range 23 to 70 years) were included in the study.
📊
Key Findings & Data:Thepulmonary function test (PFT) and cardiopulmonary exercise testing (CPET) were performed.Results: There was no significant difference between groups 1 and 2 in terms of mean age.
💡
Conclusion & Impact:While CPET parameters are affected by spinal mobility, declining aerobic capacity affects QoL.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: This study aims to evaluate the cardiopulmonary functions and exercise performance of patients with ankylosing spondylitis (AS) andto investigate the relationship between these parameters and disease activity, spine mobility and quality of life (QoL).Patients and methods: Forty-five patients with AS (group 1; 33 males, 12 females; mean age 43.1±12.1 years; range 22 to 70 years) and 30 controlsubjects (group 2; 23 males, 7 females; mean age 42.8±10.0; range 23 to 70 years) were included in the study. Disease activity was assessed with theBath Ankylosing Spondylitis Disease Activity Index and spinal mobility measures with the Bath Ankylosing Spondylitis Metrology Index (BASMI). TheAnkylosing Spondylitis Quality of Life (ASQoL) Questionnaire and the Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) were used. Thepulmonary function test (PFT) and cardiopulmonary exercise testing (CPET) were performed.Results: There was no significant difference between groups 1 and 2 in terms of mean age. The peak expiratory flow value in PFT was significantlylower in group 1 (p<0.05). In group 1, the duration of CPET was significantly shorter, and maximum work load and metabolic equivalent weresignificantly lower than in group 2 (p<0.001). Maximum oxygen uptake (VO2max) in peak responses, work and heart rate were significantly lower ingroup 1. The duration of CPET and maximum work were negatively correlated with age and BASMI (p<0.001). VO2max was negatively correlated withage, MASES and ASQoL (p<0.05).Conclusion: There was no significant difference in PFT parameters between the groups. On the other hand, CPET parameters were significantlylower in the AS group. While CPET parameters are affected by spinal mobility, declining aerobic capacity affects QoL.

🔖

Cite This Article

TÜRK, A. Ç., ARSLAN, S., KARAVELİOĞLU, Y., KALÇIK, M., ÖZEL, S., MUSMUL, A., ŞAHİN, F. (2019). Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. art, Cilt: 34 - Sayı: 3, 317–325. https://ajindex.com/articles/351672

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379-90
  2. El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 2011;22:554-60
  3. Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum 1993;22:319-34
  4. Carbon RJ, Macey MG, McCarthy DA, Pereira FP, Perry JD, Wade AJ. The effect of 30 min cycle ergometry on ankylosing spondylitis. Br J Rheumatol 1996;35:167-77
  5. Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation 1973;48:1014-27
  6. Gould BA, Turner J, Keeling DH, Hickling P, Marshall AJ. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis 1992;51:227-32
  7. Carter R, Riantawan P, Banham SW, Sturrock RD. An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis. Respir Med 1999;93:700-8
  8. Hsieh LF, Wei JC3, Lee HY, Chuang CC, Jiang JS, Chang KC. Aerobic capacity and its correlates in patients with ankylosing spondylitis. Int J Rheum Dis 2016;19:490-9
  9. O’Dwyer T, O’Shea F, Wilson F. Decreased physical activity and cardiorespiratory fitness in adults with ankylosing spondylitis: a cross-sectional controlled study. Rheumatol Int 2015;35:1863-72
  10. Fisher LR, Cawley MI, Holgate ST. Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis. Ann Rheum Dis 1990;49:921-5
  11. Feltelius N, Hedenström H, Hillerdal G, Hällgren R. Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis 1986;45:736-40
  12. Franssen MJ, van Herwaarden CL, van de Putte LB, Gribnau FW. Lung function in patients with ankylosing spondylitis. A study of the influence of disease activity and treatment with nonsteroidal antiinflammatory drugs. J Rheumatol 1986;13:936-40
  13. Heeneman S, Daemen MJ. Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol 2007;19:358-62
  14. Seçkin U, Bölükbasi N, Gürsel G, Eröz S, Sepici V, Ekim N. Relationship between pulmonary function and exercise tolerance in patients with ankylosing spondylitis. Clin Exp Rheumatol 2000;18:503-6
  15. Ceylan E. Cardiopulmonary exercise testing. J Clin Exp Invest 2014;5:504-9
  16. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGil